ESC Premium Access

Low-dose rivaroxaban during the acute phase of ACS - H-REPLACE Trial)

Congress Presentation

About the speaker

Professor Shenghua Zhou

The Second Xiangya Hospital of Central South University, Changsha (China)
1 presentation
0 follower

3 more presentations in this session

QUORUM : Quantum Genomics Firibastat (QGC001) or Ramipril after Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction

Speaker: Professor G. Montalescot (Paris, FR)


HUYGENS: Evolocumab and changes in plaque composition on OCT

Speaker: Professor S. Nicholls (Melbourne, AU)


ACCOST-HH: Adrecizumab in cardiogenic shock

Speaker: Doctor M. Karakas (Hamburg, DE)


Access the full session

Late Breaking Trials in ACS

Speakers: Professor S. Zhou, Professor G. Montalescot, Professor S. Nicholls, Doctor M. Karakas

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb